Penumbra Inc.
Penumbra, Inc. Reports Strong Fourth Quarter and Full Year 2025 Financial Results
Summary
Penumbra, Inc. reported significant revenue growth for the fourth quarter and full year 2025. Total revenue for Q4 2025 was $385.4 million, a 22.1% increase from Q4 2024, with constant currency growth of 20.9%. For the full year 2025, total revenue was $1,403.7 million, a 17.5% increase from 2024, with constant currency growth of 16.9%. The company also reported a net income of $47.3 million for Q4 2025 and $177.7 million for the full year 2025. Income from operations for Q4 2025 was $59.2 million with an operating margin of 15.4%, and for the full year, it was $189.2 million with an operating margin of 13.5%. Adjusted EBITDA for Q4 2025 was $79.1 million with an adjusted EBITDA margin of 20.5%, and for the full year, it was $266.8 million with an adjusted EBITDA margin of 19.0%. The company did not provide financial guidance for 2026 due to the proposed acquisition by Boston Scientific Corporation.
Profitelligence Alerts
Get alerts for PEN
Be first to know when Penumbra Inc. files with the SEC.
Filing Categories
Advertisement
About Penumbra Inc.
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the company operates within the specialized field of interventional therapies, particularly in neuro and vascular medical devices. Penumbra’s products are crucial for addressing critical conditions such as stroke and peripheral artery diseases. By pioneering minimally invasive solutions, the company significantly contributes to enhancing patient outcomes and reshaping intervention methods in the medical field. Founded in 2004 and headquartered in Alameda, California, Penumbra plays a vital role in the medical device industry with its commitment to advancing healthcare technologies. Its solutions are not only pivotal in specialized medical procedures but also support the healthcare ecosystem's broader objective of improving care and saving lives, making it a key entity amongst healthcare providers and hospitals worldwide.
Official SEC Documents
Advertisement